Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.
about
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in UgandaMolecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria.Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in TanzaniaReliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania.Characterization of the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase gene in samples from Equatorial Guinea before implementation of artemisinin-based combination therapy.Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policySelection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, TanzaniaDifferent patterns of pfcrt and pfmdr1 polymorphism in Plasmodium falciparum isolates from Tehama region, Yemen.Malaria in urban, semi-urban and rural areas of southern of Gabon: comparison of the Pfmdr 1 and Pfcrt genotypes from symptomatic children.Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.Survey of Plasmodium falciparum multidrug resistance-1 and chloroquine resistance transporter alleles in Haiti.Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Prevalence of pfmdr1 alleles associated with artemether-lumefantrine tolerance/resistance in Maputo before and after the implementation of artemisinin-based combination therapy.Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.Isolation and synthesis of falcitidin, a novel myxobacterial-derived acyltetrapeptide with activity against the malaria target falcipain-2.Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana.Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
P2860
Q28125904-9B3DC5FE-684D-4819-B0A2-1E397B7B149FQ33721915-852E10BC-13BD-482C-91BE-756D80F85BB9Q33905089-97DA782A-4ECD-44E2-8A14-367F9B387510Q36284299-9138E959-AB03-4782-98A7-0539A33FE3D0Q36523053-795DB436-A7C2-48EA-911D-767FACADAD19Q36669135-79CA1639-F298-4964-B544-BC9383B700F0Q36835042-1E5AB860-2809-48A5-B50E-F2482E6405F8Q37038288-0630CA13-0DE0-4752-8C01-05AA0821268CQ37066203-7F6E78C6-6387-49A0-8524-BE7DC76CCB66Q37107768-3CCEE23F-127F-4804-A6AA-D1FAB71080D7Q37188820-9977608C-94CD-4175-B7B7-563B8F5A17E2Q37285721-76400B2A-BA70-4D0B-9623-546D78F1DD3DQ37315266-C4DEB59C-CF24-4D6F-AA20-60ABADAB5230Q37326702-9C5709AB-476C-42DE-B764-AA6AE5AC4A04Q37427816-CF50AF1D-E342-4F0E-8A96-201A851FB787Q37583332-30E613AF-983A-485C-9B52-15ACCB30FA05Q38529669-3D10257F-756B-4F0D-8AF5-958DB4D2F324Q42246640-24F408C7-944F-473C-B16F-5361B93B9785Q48024028-C96E45D2-4495-4C0E-838F-B657551726ABQ48031660-AE07DFDD-3DDE-492C-B1A9-5F1A599477B9Q52628503-3AC83BBB-9A54-4F3B-BB32-36CDA0DA97BFQ58546525-2663EE2D-0487-4786-94C9-D286878B3165
P2860
Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Prevalence of single nucleotid ...... nin-based combination therapy.
@ast
Prevalence of single nucleotid ...... nin-based combination therapy.
@en
type
label
Prevalence of single nucleotid ...... nin-based combination therapy.
@ast
Prevalence of single nucleotid ...... nin-based combination therapy.
@en
prefLabel
Prevalence of single nucleotid ...... nin-based combination therapy.
@ast
Prevalence of single nucleotid ...... nin-based combination therapy.
@en
P2093
P2860
P50
P921
P1476
Prevalence of single nucleotid ...... nin-based combination therapy.
@en
P2093
Bruno P Mmbando
John P Lusingu
Lasse S Vestergaard
P2860
P304
P356
10.4269/AJTMH.2011.11-0071
P407
P577
2011-12-01T00:00:00Z